SOFW SOFWAVE MEDICAL LTD

Sofwave to Participate in Upcoming November Investor Conferences

Sofwave to Participate in Upcoming November Investor Conferences

SAN CLEMENTE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that management will participate in the following investor conferences:

Stifel 2025 Healthcare Conference

Presentation Format: Corporate overview

Presentation Date: Wednesday, November 12, 2025

Presentation Time: 10:40 a.m. ET

Webcast:

Jefferies London Healthcare Conference

Presentation Format: Corporate overview

Presentation Date: Wednesday, November 19, 2025

Presentation Time: 9:30 a.m. GMT

Webcast:

Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Presentation Format: Corporate overview

Presentation Date: Thursday, November 20, 2025

Presentation Time: 9:30 a.m. ET

Webcast:

About Sofwave Medical

 has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology, is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), improving the appearance of skin laxity on the upper arms., as well as the short-term improvement in the appearance of cellulite and treatment of acne scars. The company’s Pure Impact™ module uses EMS technology and is cleared for muscle toning. Sofwave’s products provide physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: 

Investor Contact:

Brian Ritchie

LifeSci Advisors LLC

(212) 915-2578



EN
29/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SOFWAVE MEDICAL LTD

 PRESS RELEASE

Sofwave to Participate in Upcoming November Investor Conferences

Sofwave to Participate in Upcoming November Investor Conferences SAN CLEMENTE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that management will participate in the following investor conferences: Stifel 2025 Healthcare ConferencePresentation Format: Corporate overviewPresentation Date: Wednesday, November 12, 2025Presentation Time: 10:40 a.m. ETWebcast: Jefferies London Healthcare Conference Presentation Format: Corporate overviewPresentation Date: ...

 PRESS RELEASE

Sofwave to Participate in the Jefferies Virtual Private MedTech Summit

Sofwave to Participate in the Jefferies Virtual Private MedTech Summit SAN CLEMENTE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the Jefferies Virtual Private MedTech Summit on October 1st, 2025. About Sofwave Medical has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology...

 PRESS RELEASE

Sofwave Receives FDA, Pre-market Clearance for Pure Impact VIPTM Stand...

Sofwave Receives FDA, Pre-market Clearance for Pure Impact VIPTM Standalone EMS Device For Comprehensive Multi-Body Area Muscle Strengthening and Firming The Pure Impact VIP™ standalone device represents a major extension of the Pure Impact™ product line and introduces an all-in-one independent unitStandalone device is launched with an enhanced Pure Impact™ feature set which provides comprehensive muscle strengthening programs that focus on multiple body areas including the: abdomen, arms, thighs, and buttocks and enables simultaneous treatment of 6 muscle groupsIn the recent McKinsey Life ...

 PRESS RELEASE

Sofwave to Participate in 10th Annual Needham Virtual MedTech & Diagno...

Sofwave to Participate in 10th Annual Needham Virtual MedTech & Diagnostics Conference SAN CLEMENTE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference on August 11 – 12, 2025. About Sofwave Medical has implemented an innovative approach to wrinkle reducti...

 PRESS RELEASE

Sofwave Medical Reports Record Second Quarter and First Half 2025 Fina...

Sofwave Medical Reports Record Second Quarter and First Half 2025 Financial Results and Business Highlights • Quarterly record revenue in Q2 of $21M, +43% year-over-year growth; IFRS gross margin of 75.5% • Second quarter pulse recurring revenue of $9.2M, +53% year-over-year growth • First half revenue of $37.6M, +35% year-over-year growth; IFRS gross margin of 75.9% • Generated $3.6M in cash in the second quarter • Positive first half and second quarter IFRS and Non-IFRS operating and net income vs first half loss in the same year ago period • Over 600,000 treatments completed since i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch